上一条： Novel trifluoromethyl ketone derivatives as oral cPLA(2)/COX-2 dual inhibitors for resolution of inflammation in rheumatoid arthritis.

下一条： Improving treatment for Parkinson's disease: Harnessing photothermal and phagocytosis-driven delivery of levodopa nanocarriers across the blood-brain barrier